BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24453047)

  • 1. Identification of FHL2-regulated genes in liver by microarray and bioinformatics analysis.
    Ng CF; Xu JY; Li MS; Tsui SK
    J Cell Biochem; 2014 Apr; 115(4):744-53. PubMed ID: 24453047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FHL2 regulation in the transcriptional circuitry of human cancers.
    Cao CY; Mok SW; Cheng VW; Tsui SK
    Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
    J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
    Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
    Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
    Matulis CK; Mayo KE
    Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells.
    Xu J; Zhou J; Li MS; Ng CF; Ng YK; Lai PB; Tsui SK
    PLoS One; 2014; 9(8):e99359. PubMed ID: 25121502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of FHL2 attenuates airway inflammation in mice and genetic variation associates with human bronchial hyper-responsiveness.
    Kurakula K; Vos M; Logiantara A; Roelofs JJ; Nieuwenhuis MA; Koppelman GH; Postma DS; Brandsma CA; Sin DD; Bossé Y; Nickle DC; van Rijt LS; de Vries CJ
    Allergy; 2015 Dec; 70(12):1531-44. PubMed ID: 26222912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
    Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.
    Rachmin I; Amsalem E; Golomb E; Beeri R; Gilon D; Fang P; Nechushtan H; Kay G; Guo M; Yiqing PL; Foo RS; Fisher DE; Razin E; Tshori S
    Int J Cardiol; 2015 Sep; 195():85-94. PubMed ID: 26025865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice.
    Huss S; Stellmacher C; Goltz D; Khlistunova I; Adam AC; Trebicka J; Kirfel J; Büttner R; Weiskirchen R
    BMC Gastroenterol; 2013 Jan; 13():8. PubMed ID: 23311569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL2-driven molecular network mediated Septin2 knockdown inducing apoptosis in mesangial cell.
    Lu Y; Cai G; Cui S; Geng W; Chen D; Wen J; Zhang Y; Zhang F; Xie Y; Fu B; Chen X
    Proteomics; 2014 Nov; 14(21-22):2485-97. PubMed ID: 25103794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of FHL2 in cancer.
    Zhang J; Zeng Q; She M
    Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle Cell.
    Liu Z; Han S; Wang Y; Cui C; Zhu Q; Jiang X; Yang C; Du H; Yu C; Li Q; He H; Shen X; Chen Y; Zhang Y; Ye L; Zhang Z; Li D; Zhao X; Yin H
    Int J Biol Sci; 2019; 15(4):838-846. PubMed ID: 30906214
    [No Abstract]   [Full Text] [Related]  

  • 16. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release.
    Leite Dantas R; Brachvogel B; Schied T; Bergmeier V; Skryabin B; Vogl T; Ludwig S; Wixler V
    Am J Pathol; 2017 Nov; 187(11):2388-2398. PubMed ID: 28823868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
    Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
    Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.